NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) vs State Street SPDR S&P Biotech ETF — how do they compare? NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) trades at $17.13 (market cap $66.98B), while State Street SPDR S&P Biotech ETF trades at $153.7 (market cap $10.11B). The key difference: NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) is far larger — about 6.6× State Street SPDR S&P Biotech ETF's market cap, and NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) pays a 5.5% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) for 1 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| NWG | XBI | |
|---|---|---|
Market Cap | $66.98B | $10.11B |
Volume | 5,259,060 | 12,903,266 |
Sector | Financials | Broad Market / Factor |
52-Week High | $19.42 | $169.55 |
52-Week Low | $13.89 | $104.99 |
Typical Hold Time | 1 Days | 38 Days |
Enterprise Value | $140.55B | — |
Dividend Yield | 5.5% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
Trailing returns across standard periods
NatWest Group is a UK banking company serving personal, business, and institutional customers. Its services include deposits, lending, payments, and wealth management.
Read more on NWG →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →